Keywords
Exploration
Accueil
Racine
Exploration
Accueil
Racine

La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Membrane Transport Proteins »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Membrane Proteins (physiology) < Membrane Transport Proteins < Membrane Transport Proteins (deficiency)  Facettes :

List of bibliographic references indexed by Membrane Transport Proteins

Number of relevant bibliographic references: 16.
Ident.Authors (with country if any)Title
002968 (2005) Wing Lok Au [Canada] ; John R. Adams ; André R. Troiano ; A Jon StoesslParkinson's disease: in vivo assessment of disease progression using positron emission tomography.
002D61 (2003) Doris J. Doudet [Canada] ; James E. HoldenRaclopride studies of dopamine release: dependence on presynaptic integrity.
002E13 (2003) Raúl De La Fuente-Fernández [Canada] ; Sarah Furtado [Canada] ; Mark Guttman [Canada] ; Yoshiaki Furukawa [Canada] ; Chong S. Lee [Canada] ; Donald B. Calne [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada]VMAT2 binding is elevated in dopa‐responsive dystonia: Visualizing empty vesicles by PET
003308 (2001) M. Guttman [Canada] ; D. Stewart [Canada] ; D. Hussey [Canada] ; A. Wilson [Canada] ; S. Houle [Canada] ; S. Kish [Canada]Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD
003363 (2000) Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
003440 (2000) Sophie Callier [Canada, France] ; Marc Morissette [Canada] ; Michelle Grbois [Canada] ; Thérèse Di Paolo [Canada]Stereospecific prevention by 17β‐estradiol of MPTP‐induced dopamine depletion in mice
003485 (2000) Chong S. Lee [Canada] ; Ali Samii [Canada] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; Michael Schulzer [Canada] ; James E. Holden [États-Unis] ; Jess Wudel [Canada] ; Pramod K. Pal [Canada] ; Raul De La Fuente-Fernandez [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada]In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease
003513 (2000) J. M. Van Kampen [Canada] ; E. G. Mcgeer [Canada] ; A. Jon Stoessl [Canada]Dopamine transporter function assessed by antisense knockdown in the rat: Protection from dopamine neurotoxicity
003618 (1999) D C Vines [Canada] ; B D Ivo ; J R Ballinger ; M. IchiseExternal radioactive reference markers in SPECT imaging of the dopamine system.
003800 (1999) M. Ichise [Canada] ; Y. J. Kim [Canada] ; J. R. Ballinger [Canada] ; D. Vines [Canada] ; S. S. Erami [Canada] ; F. Tanaka [Canada] ; A. E. Lang [Canada]SPECT imaging of pre- and postsynaptic dopaminergic alterations in L-dopa-untreated PD
003822 (1999) M. Ichise [Canada] ; Y. J. Kim ; S. S. Erami ; J. R. Ballinger ; D. Vines ; F. Tanaka ; A. E. LangFunctional morphometry of the striatum in Parkinson's disease on three-dimensional surface display of 123I-β-CIT SPECT data
003A60 (1997) M. Guttman [Canada] ; J. Burkholder ; S J Kish ; D. Hussey ; A. Wilson ; J. Dasilva ; S. Houle[11C]RTI-32 PET studies of the dopamine transporter in early dopa-naive Parkinson's disease: implications for the symptomatic threshold.
003C88 (1996) X. Fang [Canada] ; F E Parkinson ; D A Mowles ; J D Young ; C E CassFunctional characterization of a recombinant sodium-dependent nucleoside transporter with selectivity for pyrimidine nucleosides (cNT1rat) by transient expression in cultured mammalian cells.
003E62 (1996) Christopher M. Anderson [Canada] ; Wei Xiong [Canada] ; James D. Young [Canada] ; Carol E. Cass [Canada] ; Fiona E. Parkinson [Canada]Demonstration of the existence of mRNAs encoding N1/ cif and N2/ cit sodium/nucleoside cotransporters in rat brain
004813 (1991) H. B. Niznik ; E. F. Fogel ; F. F. Fassos ; P. SeemanThe dopamine transporter is absent in parkinsonian putamen and reduced in the caudate nucleus
004855 (1990) P. Seeman [Canada] ; H B NiznikDopamine receptors and transporters in Parkinson's disease and schizophrenia.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Membrane Transport Proteins" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Membrane Transport Proteins" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Membrane Transport Proteins
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022